|
Featured Company: OXYGENIX Co., Ltd.
|
■Company Name： |
OXYGENIX Co., Ltd. |
|
■Company Address： |
Toranomon Pastoral Main building 6F
4-1-1 Toranomon, Minato-ku, Tokyo 105-0001
TEL- 03-5733-1683 / FAX- 03-5733-1643 |
|
■Homepage Address： |
http://www.oxy-genix.com/english/top/index.html |
|
■Email Contact： |
info@oxy-genix.com |
|
■President： |
Takao Ohmura, Ph.D. |
|
■Principal Area of Business： |
Research, development and production of oxygen carriers; Oxygenix is developing the world's first cell-type Oxygen Carrier, OXY-0301. It will also develop new protein-based drugs using its unique formulation technology exploited through OXY-0301. |
|
■Principal Products/BusinessActivities： |
l Oxygenix's leading product candidate, OXY-0301, is an Oxygen Carrier that contributes to the stable supply of safe erythrocyte products.
l Another product candidate is a liposome which encapsulates an enzyme related to a certain disease. |
|
■Business Goals： |
To supply effective and safe drugs that fulfill unmet medical needs, based on our innovative, proprietary DDS(Drug Delivery System) technology; to contribute to human health and QOL(Quality Of Life) of people around the world; and to return profits to shareholders, business partners, employees and society in general through development of superior drugs. |
|
■Year of Establishment： |
December 19, 2002 |
|
■Company Photo： |
|
|
